Eight months in, Nigel Hughes, Scientific Director JCI-PDR, Janssen, examines the ramifications of...
- British universities must improve clinical trial reporting, says House of Commons
- Expert Insights: Moderna Therapeutics Barrels Ahead Towards Historic IPO
- Industry Viewpoints: Leveraging eSource in Data Management
- The Fundamentals Behind Effective Data Management
- We Need to Talk About Race: Lack of Diversity in Clinical Trials is a Public Health Issue
British universities must improve clinical trial reporting, says House of Commons
The House of Commons Science and Technology Select Committee has announced that UK universities could be brought in for questioning if they fail to improve the transparency of their clinical trial procedure.
Report finds 800 UK university trials could become research waste
A new report by TranspariMED and Universities Allies for Essential Medicines UK has found that as many as 800 clinical trials by UK universities could become research waste as they violate reporting rules.
Industry Viewpoints: The Challenges of Clinical Data Management
In this Industry Viewpoint, Sarah Fal speaks to Kumar Komuravelli, Mallinckrodt Pharmaceuticals, on the arising technologies taking over the industry
Expert Insights: Moderna Therapeutics Barrels Ahead Towards Historic IPO
Paul Jeng, PhD, Infectious Diseases Analyst, GlobalData, analyzes Moderna Therapeutics’ growing stature as the young biotech punches above its weight
Industry Viewpoints: Leveraging eSource in Data Management
CTA’s Sarah Fal interviews Terry Katz, Merck Animal Health, on the latest clinical data management trends and challenges
Enriched Evidence Generation: Linking Clinical Data, Registries and Patient-Reported Outcomes to Health Care Utilization
Eric Van Ganse, Manon Belhassen, PELyon, & Francois Gavini, Roche, explain how French national claims data can deliver critical value to clinical trials and patients registries